Literature DB >> 28019709

Exogenous induction of unphosphorylated PTEN reduces TGFβ-induced extracellular matrix expressions in lung fibroblasts.

Motohiro Kimura1, Naozumi Hashimoto1, Masaaki Kusunose1, Daisuke Aoyama1, Koji Sakamoto1, Shinichi Miyazaki1, Akira Ando1, Norihiro Omote1, Kazuyoshi Imaizumi2, Tsutomu Kawabe3, Yoshinori Hasegawa1.   

Abstract

Transforming growth factor β (TGFβ) plays an important role in regulating aberrant extracellular matrix (ECM) production from alveolar/epithelial cells (AECs) and fibroblasts in pulmonary fibrosis. Although the tumor suppressor gene phosphatase and tensin homologue deleted from chromosome 10 (PTEN) can negatively control many TGFβ-activated signaling pathways via the phosphatase activity, hyperactivation of the TGFβ-related signaling pathways is often observed in fibrosis. Loss of PTEN expression might cause TGFβ-induced ECM production. In addition, TGFβ was recently shown to induce loss of PTEN enzymatic activity by phosphorylating the PTEN C-terminus. Therefore, we hypothesized that exogenous transfer of unphosphorylated PTEN (PTEN4A) might lead to reduce TGFβ-induced ECM expression in not only epithelial cells but also fibroblasts. Adenovirus-based exogenous PTEN4A induction successfully reduced TGFβ-induced fibronectin expression and retained β-catenin at the cell membrane in human epithelial cells. Exogenous unphosphorylated PTEN also attenuated TGFβ-induced ECM production and inhibited TGFβ-induced β-catenin translocation in a human fibroblast cell line and in mouse primary isolated lung fibroblasts. Conversely, TGFβ-induced α-smooth muscle actin expression did not seem to be inhibited in these fibroblasts. Our data suggest that exogenous administration of unphosphorylated PTEN might be a promising strategy to restore TGFβ-induced loss of PTEN activity and reduce aberrant TGFβ-induced ECM production from epithelial cells and fibroblasts in lung fibrosis as compared with wild-type PTEN induction.
© 2016 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28019709     DOI: 10.1111/wrr.12506

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  6 in total

Review 1.  The functions of tumor suppressor PTEN in innate and adaptive immunity.

Authors:  Lang Chen; Deyin Guo
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

2.  miR-338-3p blocks TGFβ-induced myofibroblast differentiation through the induction of PTEN.

Authors:  Ashley R Rackow; Jennifer L Judge; Collynn F Woeller; Patricia J Sime; Robert M Kottmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-01-05       Impact factor: 5.464

Review 3.  PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases.

Authors:  Bangrong Cai; Liu Yang; Young Do Jung; Ying Zhang; Xinguang Liu; Peng Zhao; Jiansheng Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-30       Impact factor: 7.310

4.  Repressive role of stabilized hypoxia inducible factor 1α expression on transforming growth factor β-induced extracellular matrix production in lung cancer cells.

Authors:  Akira Ando; Naozumi Hashimoto; Koji Sakamoto; Norihito Omote; Shinichi Miyazaki; Yoshio Nakahara; Kazuyoshi Imaizumi; Tsutomu Kawabe; Yoshinori Hasegawa
Journal:  Cancer Sci       Date:  2019-05-13       Impact factor: 6.716

Review 5.  Targeting TGF-β signal transduction for fibrosis and cancer therapy.

Authors:  Dandan Peng; Minyang Fu; Manni Wang; Yuquan Wei; Xiawei Wei
Journal:  Mol Cancer       Date:  2022-04-23       Impact factor: 41.444

Review 6.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.